A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
Public ClinicalTrials.gov record NCT06920004. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-Blinded, Double-Dummy Study Evaluating the Efficacy and Safety of Intravenous Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy
Study identification
- NCT ID
- NCT06920004
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- argenx
- Industry
- Enrollment
- 218 participants
Conditions and interventions
Conditions
Interventions
- IVIg Biological
- IVIg-placebo Other
- empasiprubart Biological
- empasiprubart-placebo Other
Biological · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 21, 2025
- Primary completion
- Aug 31, 2027
- Completion
- Aug 31, 2030
- Last update posted
- May 7, 2026
2025 – 2030
United States locations
- U.S. sites
- 11
- U.S. states
- 8
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Samir Macwan, M.D., Inc. | Rancho Mirage | California | 922701 | Recruiting |
| Colorado Springs Neurological Associates | Colorado Springs | Colorado | 80907 | Recruiting |
| MedStar Washington Hospital Center | Washington D.C. | District of Columbia | 20010 | Recruiting |
| Homestead Associates in Research Inc | Homestead | Florida | 33033 | Recruiting |
| Visionary Investigators Network | Miami | Florida | 33133 | Recruiting |
| University of South Florida | Tampa | Florida | 33616 | Recruiting |
| Paradigm Health System | Slidell | Louisiana | 70458 | Recruiting |
| Erlanger Health System | Columbia | Maryland | 21044 | Recruiting |
| University of Michigan Hospital | Ann Arbor | Michigan | 48109 | Recruiting |
| NeuroCarePlus | Houston | Texas | 77094 | Recruiting |
| National Neuromuscular Research Institute | Irving | Texas | 75063 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 62 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06920004, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 7, 2026 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06920004 live on ClinicalTrials.gov.